BrightSpring Health Services, Inc. (NASDAQ:BTSG) Position Reduced by J. Goldman & Co LP

J. Goldman & Co LP reduced its position in shares of BrightSpring Health Services, Inc. (NASDAQ:BTSG) by 55.5% in the fourth quarter, HoldingsChannel.com reports. The firm owned 1,258,619 shares of the company’s stock after selling 1,569,228 shares during the period. J. Goldman & Co LP’s holdings in BrightSpring Health Services were worth $21,434,000 at the end of the most recent reporting period.

Several other hedge funds also recently modified their holdings of BTSG. Barclays PLC grew its holdings in BrightSpring Health Services by 22.2% during the third quarter. Barclays PLC now owns 393,725 shares of the company’s stock worth $5,780,000 after acquiring an additional 71,633 shares during the period. JPMorgan Chase & Co. boosted its holdings in BrightSpring Health Services by 275.2% during the third quarter. JPMorgan Chase & Co. now owns 163,618 shares of the company’s stock worth $2,402,000 after buying an additional 120,005 shares in the last quarter. SG Americas Securities LLC grew its position in BrightSpring Health Services by 50.9% in the fourth quarter. SG Americas Securities LLC now owns 37,000 shares of the company’s stock worth $630,000 after buying an additional 12,486 shares during the last quarter. R Squared Ltd bought a new position in shares of BrightSpring Health Services in the fourth quarter valued at $74,000. Finally, Legato Capital Management LLC lifted its position in shares of BrightSpring Health Services by 40.0% during the 4th quarter. Legato Capital Management LLC now owns 66,910 shares of the company’s stock valued at $1,139,000 after acquiring an additional 19,120 shares during the last quarter.

Wall Street Analyst Weigh In

A number of equities research analysts have recently issued reports on the company. Mizuho set a $26.00 target price on BrightSpring Health Services in a research report on Monday, May 5th. UBS Group upped their price objective on shares of BrightSpring Health Services from $22.00 to $30.00 and gave the company a “buy” rating in a research note on Wednesday, January 29th. Finally, Morgan Stanley lifted their target price on shares of BrightSpring Health Services from $20.00 to $25.00 and gave the stock an “overweight” rating in a research report on Friday. One investment analyst has rated the stock with a hold rating and nine have assigned a buy rating to the company. According to data from MarketBeat.com, BrightSpring Health Services presently has a consensus rating of “Moderate Buy” and an average target price of $22.89.

BrightSpring Health Services Trading Up 1.3 %

Shares of NASDAQ BTSG opened at $22.82 on Friday. The business has a 50 day simple moving average of $17.96 and a 200 day simple moving average of $18.72. BrightSpring Health Services, Inc. has a 52 week low of $10.15 and a 52 week high of $24.82. The stock has a market cap of $3.98 billion, a price-to-earnings ratio of -87.77 and a beta of 2.06. The company has a debt-to-equity ratio of 1.63, a quick ratio of 0.97 and a current ratio of 1.35.

BrightSpring Health Services (NASDAQ:BTSG) last posted its earnings results on Friday, May 2nd. The company reported $0.19 EPS for the quarter, topping the consensus estimate of $0.09 by $0.10. BrightSpring Health Services had a negative net margin of 0.38% and a positive return on equity of 4.16%. The company had revenue of $2.88 billion during the quarter, compared to the consensus estimate of $2.74 billion. During the same period in the previous year, the firm posted $0.12 earnings per share. The company’s revenue for the quarter was up 25.9% compared to the same quarter last year. On average, research analysts predict that BrightSpring Health Services, Inc. will post 0.59 earnings per share for the current fiscal year.

BrightSpring Health Services Profile

BrightSpring Health Services, Inc operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.